{{Rsnum
|rsid=2032487
|Gene=MYH9
|Chromosome=22
|position=36299382
|Orientation=plus
|GMAF=0.1809
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=MYH9
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.0 | 0.0 | 0.0
| HCB | 0.0 | 0.0 | 100.0
| JPT | 0.0 | 0.0 | 100.0
| YRI | 57.1 | 38.1 | 4.8
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.0 | 0.0 | 100.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=19567477
|Title=Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRD
|OA=1
}}

{{omim
|desc=FOCAL SEGMENTAL GLOMERULOSCLEROSIS 4, SUSCEPTIBILITY TO; FSGS4
|id=612551
|rsnum=2032487
}}

{{PMID Auto
|PMID=19153477
|Title=Polymorphisms in the nonmuscle myosin heavy chain 9 gene (MYH9) are associated with albuminuria in hypertensive African Americans: the HyperGEN study
|OA=1
}}

{{PMID Auto
|PMID=21968013
|Title=Polymorphisms in MYH9 are associated with diabetic nephropathy in European Americans
|OA=1
}}

{{PMID Auto
|PMID=18794854
|Title=MYH9 is associated with nondiabetic end-stage renal disease in African Americans.
|OA=1
}}

{{PMID Auto
|PMID=18794856
|Title=MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis.
|OA=1
}}

{{PMID Auto
|PMID=19177153
|Title=Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans.
|OA=1
}}

{{PMID Auto
|PMID=19764949
|Title=Potential donor-recipient MYH9 genotype interactions in posttransplant nephrotic syndrome after pediatric kidney transplantation.
|OA=1
}}

{{PMID Auto
|PMID=20124285
|Title=Dense mapping of MYH9 localizes the strongest kidney disease associations to the region of introns 13 to 15.
|OA=1
}}

{{PMID Auto
|PMID=20144966
|Title=African ancestry allelic variation at the MYH9 gene contributes to increased susceptibility to non-diabetic end-stage kidney disease in Hispanic Americans.
|OA=1
}}

{{PMID Auto
|PMID=20634883
|Title=Worldwide distribution of the MYH9 kidney disease susceptibility alleles and haplotypes: evidence of historical selection in Africa.
|OA=1
}}

{{PMID Auto
|PMID=22956460
|Title=Genetic variation in APOL1 and MYH9 genes is associated with chronic kidney disease among Nigerians.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}